A detailed history of Boothbay Fund Management, LLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 129,438 shares of KOD stock, worth $801,221. This represents 0.01% of its overall portfolio holdings.

Number of Shares
129,438
Previous 129,438 -0.0%
Holding current value
$801,221
Previous $304,000 10.86%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$3.01 - $7.45 $106,201 - $262,858
35,283 Added 37.47%
129,438 $680,000
Q4 2023

Feb 14, 2024

BUY
$1.4 - $3.24 $37,394 - $86,540
26,710 Added 39.6%
94,155 $286,000
Q3 2023

Nov 14, 2023

BUY
$1.8 - $7.49 $98,362 - $409,298
54,646 Added 426.96%
67,445 $121,000
Q2 2023

Aug 14, 2023

SELL
$4.3 - $9.48 $88,021 - $194,055
-20,470 Reduced 61.53%
12,799 $88,000
Q1 2023

May 15, 2023

BUY
$4.81 - $8.88 $160,023 - $295,428
33,269 New
33,269 $206,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $322M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.